Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience
ConclusionHistory of CLL did not independently affect OS in t-MDS patients beyond IPSS-R score.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Carisoprodol | Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia | Lymphoma | Myelodysplastic Syndrome | Myeloma | Rituxan | Soma